These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29401149)

  • 1. Superior Pituitary Border Analysis in Immunotherapy-Induced Hypophysitis.
    Pucar D; Boustani AM; Bronen RA; Saperstein L
    Clin Nucl Med; 2018 Apr; 43(4):284-286. PubMed ID: 29401149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The imaging of immunotherapy-related hypophysitis and other pituitary lesions in oncology patients.
    Lasocki A; Iravani A; Galligan A
    Clin Radiol; 2021 May; 76(5):325-332. PubMed ID: 33593600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-mediated Disease in Ipilimumab Immunotherapy of Melanoma with FDG PET-CT.
    Wachsmann JW; Ganti R; Peng F
    Acad Radiol; 2017 Jan; 24(1):111-115. PubMed ID: 27818005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Headache in the Setting of Immunotherapy Treatment for Metastatic Melanoma.
    Comstock DE; Nishino M; Giardino AA
    JAMA Oncol; 2017 May; 3(5):703-704. PubMed ID: 28196215
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypophysitis: Nursing Management of Immune-Related Adverse Events
.
    Vazquez A
    Clin J Oncol Nurs; 2017 Apr; 21(2):154-156. PubMed ID: 28315541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitis.
    Galligan A; Iravani A; Lasocki A; Wallace R; Weppler AM; Sachithanandan N; Chiang C; Colman PG; Wentworth J; Spain L; Au-Yeung G; Lee B; Kay TWH; Hicks RJ; Sandhu S; Krishnamurthy B
    Front Endocrinol (Lausanne); 2023; 14():1295865. PubMed ID: 38093958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ipilimumab treatment associated pituitary hypophysitis: clinical presentation and imaging diagnosis.
    Chodakiewitz Y; Brown S; Boxerman JL; Brody JM; Rogg JM
    Clin Neurol Neurosurg; 2014 Oct; 125():125-30. PubMed ID: 25127260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy-induced autoimmune diabetes and concomitant hypophysitis.
    Sum M; Garcia FV
    Pituitary; 2018 Oct; 21(5):556-557. PubMed ID: 29476305
    [No Abstract]   [Full Text] [Related]  

  • 9. Nivolumab-induced hypophysitis in a patient with advanced malignant melanoma.
    Okano Y; Satoh T; Horiguchi K; Toyoda M; Osaki A; Matsumoto S; Tomaru T; Nakajima Y; Ishii S; Ozawa A; Shibusawa N; Shimada T; Higuchi T; Chikamatsu K; Yamada M
    Endocr J; 2016 Oct; 63(10):905-912. PubMed ID: 27440480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of early onset of hypophysitis by (18)F-FDG PET-CT in a patient with advanced stage melanoma treated with ipilimumab.
    van der Hiel B; Blank CU; Haanen JB; Stokkel MP
    Clin Nucl Med; 2013 Apr; 38(4):e182-4. PubMed ID: 23455528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rare cause of hypophysitis: tuberculosis.
    Ates I; Katipoglu B; Copur B; Yilmaz N
    Endocr Regul; 2017 Oct; 51(4):213-215. PubMed ID: 29232189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MECHANISMS IN ENDOCRINOLOGY: Hypophysitis: diagnosis and treatment.
    Joshi MN; Whitelaw BC; Carroll PV
    Eur J Endocrinol; 2018 Sep; 179(3):R151-R163. PubMed ID: 29880706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypophysitis, the Growing Spectrum of a Rare Pituitary Disease.
    Langlois F; Varlamov EV; Fleseriu M
    J Clin Endocrinol Metab; 2022 Jan; 107(1):10-28. PubMed ID: 34528683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Checkpoint inhibitors-induced hypophysitis].
    du Payrat JA; Cugnet-Anceau C; Maillet D; Levy M; Raverot G; Disse E; Borson-Chazot F
    Bull Cancer; 2020 Apr; 107(4):490-498. PubMed ID: 32200950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma.
    Faje AT; Sullivan R; Lawrence D; Tritos NA; Fadden R; Klibanski A; Nachtigall L
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4078-85. PubMed ID: 25078147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody.
    Iwama S; De Remigis A; Callahan MK; Slovin SF; Wolchok JD; Caturegli P
    Sci Transl Med; 2014 Apr; 6(230):230ra45. PubMed ID: 24695685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xanthomatous hypophysitis: A rare case report with review of literature.
    Kini H; Rao R; Pai M
    Indian J Pathol Microbiol; 2019; 62(3):448-450. PubMed ID: 31361237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prednisolone-responsive Postpartum IgG4-related Hypophysitis.
    Koide H; Shiga A; Komai E; Yamato A; Fujimoto M; Tamura A; Kono T; Nakayama A; Takiguchi T; Higuchi S; Sakuma I; Nagano H; Hashimoto N; Suzuki S; Takeda Y; Shibuya M; Nishioka H; Yamada S; Inoshita N; Ishiwatari N; Horiguchi K; Yokote K; Tanaka T
    Intern Med; 2018 Feb; 57(3):367-375. PubMed ID: 29093382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypophysitis on immunotherapy with checkpoint inhibitors.
    Jäger IM; Kohlmann J; Simon JC; Sandner B; Tönjes A; Ziemer M
    J Dtsch Dermatol Ges; 2019 Nov; 17(11):1168-1170. PubMed ID: 31701648
    [No Abstract]   [Full Text] [Related]  

  • 20. Diffuse Basisphenoid Enhancement: Possible Differentiating Feature for Granulomatous Hypophysitis.
    Mark IT; Glastonbury CM
    AJNR Am J Neuroradiol; 2022 Sep; 43(9):1341-1345. PubMed ID: 36007945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.